- Home
- JKS vs IMTX Comparison
JKS vs IMTX Comparison
Compare JKS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JKS | IMTX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | China | Germany |
| Employees | N/A | 423 |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | JKS | IMTX |
|---|---|---|
| Price | $25.32 | $9.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $23.88 | $19.00 |
| AVG Volume (30 Days) | 464.4K | ★ 519.3K |
| Earning Date | 04-28-2026 | 03-05-2026 |
| Dividend Yield | ★ 5.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.42 | $45.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.42 | $3.30 |
| 52 Week High | $31.88 | $12.41 |
Technical Indicators
Market Signals| Indicator | JKS | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 49.45 |
| Support Level | $23.78 | $9.66 |
| Resistance Level | $26.06 | $10.64 |
| Average True Range (ATR) | 0.95 | 0.55 |
| MACD | 0.20 | -0.00 |
| Stochastic Oscillator | 69.98 | 40.47 |
Price Performance
Historical ComparisonAbout JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.